Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 70Triple Negative Breast Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Inflammatory Breast Neoplasms 3Seroma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Invasive Breast Cancer 2Carcinoma, Ductal, Breast 2Breast Cancer Invasive 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcoma 1Premenopausal Breast Cancer 1Patient Preference 1Pain, Postoperative 1Pain 1Neoplastic Cells, Circulating 1Neoplasms 1Myofibroma 1Mesothelioma, Malignant 1Lymphatic Metastasis 1Inflammation 1Hereditary Breast and Ovarian Cancer Syndrome 1HER2-positive Early Breast Cancer 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

Leuprolide 2pembrolizumab 1exemestane 1Tamoxifen 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Premenopausal Breast Cancer × Surgical Procedures, Operative × Breast × Clear all
NCT04997941 2024-04-23

MORE-T

Seoul National University Hospital

Phase 2 Active not recruiting
238 enrolled
Breast

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡